Director/PDMR Shareholding

Abingdon Health PLC

25 October 2023

 

Abingdon Health plc

("Abingdon Health" or the "Company")

Director Dealing

York, U.K. 25 October 2023: Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high quality, rapid diagnostic tests announces that on the 24^th October 2023, Dr Chris Hand, Non-Executive Chairman purchased ordinary shares of 0.025 pence each in the Company ("Ordinary Shares").

Further details are as follows:

Director	No. Ordinary Shares Purchased	Aggregate Purchase Price (Pence per Ordinary Share)	Enlarged Holding (No. Ordinary Shares)	Enlarged Holding* (Per cent. of Total Voting Rights)
Dr Chris Hand	150,000	10.167	13,178,467	10.83%

*Excluding options over Ordinary Shares

The Notification of Dealing Form required in accordance with UK MAR is set out below.

Enquiries:

Abingdon Health plc		www.abingdonhealth.com/investors/
Chris Yates, Chief Executive Officer		Via Walbrook PR
Chris Hand, Non-Executive Chairman
Singer Capital Markets (Sole Broker and Nominated Adviser)		Tel: [phone]
Peter Steel, Alex Bond, Jalini Kalaravy
Walbrook PR Limited	Tel: [phone] or [e-mail]
Paul McManus, Phillip Marriage, Alice Woodings	Mob: [phone] [phone]

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Dr Chris Hand
2	Reason for the notification
a)	Position/status	Non-Executive Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Abingdon Health plc
b)	LEI	213800XFI4WV3FBILO20
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of 0.025 pence each
	Identification code	GB00BLF79J41
b)	Nature of the transaction	Purchase of Ordinary Shares
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			10 pence per share 10.5 pence per share	100,000 50,000
d)	Aggregated information
	- Aggregated volume	150,000
	- Price	10.167 pence per share
e)	Date of the transaction	24th October 2023
f)	Place of the transaction	London Stock Exchange, AIM

About Abingdon Health plc

Abingdon Health is a leading lateral flow contract research ("CRO") and contract development and manufacturing organisation ("CDMO") offering its services to an international customer base across industry sectors that include clinical, animal health, plant health, and environmental testing. Abingdon Health has the internal capabilities to take projects from initial concept through to routine and large-scale manufacturing; from "idea to commercial success."

The Company's CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Abingdon Health aims to support the increase in need for rapid results across many industries and locations and produces lateral flow tests in areas such as infectious disease, clinical testing including companion diagnostics, animal health and environmental testing. Faster access to results allows for rapid decision making, targeted intervention and can support better outcomes. 

Abingdon Health's Abingdon Simply Test™ range of self-tests is an ecommerce platform that offers a range of self-tests to empowers consumers to manage their own health and wellbeing. The Abingdon Simply Test™ ecommerce site offers consumers a range of information to support them in making informed decisions on the tests available. In addition, the site provides Abingdon's contract services customers with a potential route to market for self-tests. The Abingdon Simply Test range is also sold through international distributors and through other channels in the UK and Ireland such as pharmacy chains.

Founded in 2008, Abingdon Health is headquartered in York, England.

For more information visit: www.abingdonhealth.com

 

END